Skip to main content
. Author manuscript; available in PMC: 2009 Aug 17.
Published in final edited form as: Cancer Biol Ther. 2008 May 7;7(5):709–717. doi: 10.4161/cbt.7.5.5713

Figure 5.

Figure 5

Activation of caspases 3 and 8 in SK-N-AS neuroblastoma cells following treatment with CDDO-Me. (A) dose-dependence after 6 h exposure to 0–250 nM of CDDO-Me; (B) time-courses 0–24 h of caspases 3 and 8 activation by 250 nM CDDO-Me. Experiments were performed in triplicate. Error bars represent standard errors of means for each point. AMC: 7-amino-4-methoxy coumarin.